In today’s highly competitive pharmaceutical industry, transactions such as mergers, acquisitions and divestures are important means of growth for many pharmaceutical companies. A vigorous financial and strategic analysis is essential to avoid the financial hazzards of an inappropriate transaction or the equally critical mistake of a lost commercial opportunity. Such analysis facilitates decision-making, enhances the quality of decisions and enables management to take action with greater confidence and insight.
Plexus Ventures offers consulting support via a specialist team of highly motivated entrepreneurs. The Plexus team develops a guiding strategy for our clients to spur their growth and profitability. Our work involves providing timely and effective strategic advice on aspects of corporate financing, strategic planning, portfolio building, market entry and due diligence assistance. In many cases, our evaluation and analysis form the basis of the transaction structure and negotiation resulting in an effective and efficient negotiation process.
Plexus Ventures also assists clients to develop their growth objectives and the strategies to achieve them. Our experts draw on vast industry knowledge and experience, assessment of the current situation, and analysis and interpretation of results across different markets, drawing on a wide range of local knowledge and multi-cultural perspective in the process
